Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'cpp1 7 npy19 23 ala31 aib32 gln34 hpancreatic polypeptide'

Search results for: 'cpp1 7 npy19 23 ala31 aib32 gln34 hpancreatic polypeptide'

Items 171-180 of 901

Page
per page
  1. TG100-115
    A2754 TG100-115
    Target: PI3K
    Summary: PI3Kγ/PI3Kδ inhibitor
      insoluble in H2O; insoluble in EtOH; ≥3.46 mg/mL
  2. Epothilone B (EPO906, Patupilone)
    A1630 Epothilone B (EPO906, Patupilone)
    Target: Microtubules/Tubulins
    Summary: Microtubule stabilizing macrolide
      ≥25.4 mg/mL
  3. Pelitinib (EKB-569)
    A1835 Pelitinib (EKB-569)
    Summary: EGFR inhibitor,potent and irreversible
      insoluble in EtOH; insoluble in H2O; ≥11.7 mg/mL
  4. Foretinib (GSK1363089)
    A2974 Foretinib (GSK1363089)
     1 Citation
    Summary: VEGF and HGF receptor inhibitor
      ≥31.65 mg/mL
  5. GSK1904529A
    A1302 GSK1904529A
    Target: Insulin and Insulin-like Receptors
    Summary: Selective IGF-1R/IR inhibitor
      ≥42.6 mg/mL
  6. Brivanib Alaninate (BMS-582664)
    A2633 Brivanib Alaninate (BMS-582664)
    Summary: VEGFR2 inhibitor,ATP-competitive
      ≥22.05 mg/mL
  7. Candesartan
    A5932 Candesartan
    Summary: Angiotensin II receptor 1 (AT1) antagonist
      insoluble in H2O; ≥14.65 mg/mL
  8. Febuxostat
    A5926 Febuxostat
    Summary: non-purine selective inhibitor of xanthine oxidase
      insoluble in H2O; ≥15.55 mg/mL
  9. AS-605240
    A5176 AS-605240
    Target: PI3K
    Summary: Potent and selective PI 3-Kγ inhibitor
      insoluble in H2O; insoluble in EtOH; ≥4.28 mg/mL
  10. Tigecycline
    A5226 Tigecycline
     1 Citation
    Summary: Glycylcycline antibiotic
      ≥29.3 mg/mL

Items 171-180 of 901

Page
per page
Shop By
Now Shopping by
  1. Category Signaling Pathways Remove This Item
Clear All
Shopping Options
Category
  1. Proteases 39item
  2. Apoptosis 39item
  3. Chromatin/Epigenetics 50item
  4. Metabolism 52item
  5. MAPK Signaling 26item
  6. Tyrosine Kinase 59item
  7. DNA Damage/DNA Repair 34item
  8. PI3K/Akt/mTOR Signaling 34item
  9. Microbiology & Virology 30item
  10. Cell Cycle/Checkpoint 34item
  11. Ubiquitination/ Proteasome 16item
  12. JAK/STAT Signaling 16item
  13. TGF-β / Smad Signaling 13item
  14. Angiogenesis 6item
  15. GPCR/G protein 140item
  16. Stem Cell 15item
  17. Membrane Transporter/Ion Channel 84item
  18. Cancer Biology 4item
  19. Endocrinology and Hormones 32item
  20. Neuroscience 81item
  21. Other Signal Transduction 6item
  22. Others 109item
  23. Immunology/Inflammation 24item
  24. Cardiovascular 5item
  25. Vitamin D Related 3item
  26. NF-κB 1 item
  27. Autophagy 1 item
  28. Metabolic Enzyme/Protease 24item
  29. Anti-infection 12item
  30. Immunology 1 item
Specificity
  1. Selective 146item
  2. Non-Selective 2item
Reversibility
  1. Reversible 10item
  2. Irreversible 6item
Target
  1. Caspases 3item
  2. Cyclin-Dependent Kinases 6item
  3. Proteasome 4item
  4. Cathepsins 2item
  5. Histone Deacetylases (HDACs) 9item
  6. PI3K 7item
  7. CXCR 1 item
  8. Raf 5item
  9. CSF-1R 1 item
  10. EZH2 1 item
  11. mTOR 1 item
  12. MMP 1 item
  13. Androgen Receptors 1 item
  14. Peptidylprolyl isomerases 1 item
  15. FLT3 2item
  16. GSK-3 2item
  17. Factor Xa 1 item
  18. LPA Receptors 1 item
  19. PLK 1 item
  20. VEGFR 8item
  21. PDGFR 5item
  22. c-Kit 2item
  23. RET 1 item
  24. Thymidylate Synthase 1 item
  25. p38 2item
  26. 3-phosphoglycerate dehydrogenase 1 item
  27. JNK 3item
  28. MEK 2item
  29. FGFR 4item
  30. Nrf2 1 item
  31. Liver X receptors (LXRs) 1 item
  32. Voltage-gated Sodium (NaV) Channels 1 item
  33. Deubiquitinating enzymes (DUBs) 2item
  34. PP1 1 item
  35. PP2A 1 item
  36. Eukaryotic elongation factors 1 item
  37. Ribosomal s6 kinases (RSK) 1 item
  38. Neuraminidases (NA) 1 item
  39. MET 3item
  40. Src 1 item
  41. Trk Receptors 3item
  42. NMDA Receptors 1 item
  43. STAT 1 item
  44. Microtubules/Tubulins 2item
  45. Estrogen and Related Receptors 2item
  46. EGFR 3item
  47. Reverse Transcriptases 1 item
  48. ROCK 3item
  49. BTK 1 item
  50. RIP kinases 1 item
  51. JAK 2item
  52. EZH1 1 item
  53. HSP90 1 item
  54. Angiotensin AT2 Receptors 1 item
  55. Topoisomerases 5item
  56. Cytochrome P450 (CYP450) 1 item
  57. M3 Receptors 1 item
  58. S6 kinases 1 item
  59. Toll-like receptors (TLRs) 2item
  60. Adenosine Kinases 1 item
  61. Actin 1 item
  62. Serine Proteases 1 item
  63. Epac 1 item
  64. Survivin 1 item
  65. ERK 1 item
  66. HMG-CoA Reductases 1 item
  67. Vacuolar-type ATPase 1 item
  68. c-MET 3item
  69. PKC 3item
  70. Calpains 1 item
  71. Ubiquitin-specific proteases 1 item
  72. Protease-Activated Receptors 1 item
  73. RAD51 1 item
  74. Trypsins 1 item
  75. HER2 3item
  76. 5-HT2 Receptors 1 item
  77. DGAT 1 item
  78. Insulin and Insulin-like Receptors 1 item
  79. PARP 2item
  80. CB1 Receptors 1 item
  81. ALK 4item
  82. ROS1 1 item
  83. NK1 Receptors 1 item
  84. Dehydrogenase 1 item
  85. PKG 2item
  86. PKA 2item
  87. Myosin light chain kinases (MLCKs) 3item
  88. HIV-1 gp120 1 item
  89. D1 and D5 Receptors 1 item
  90. D2 Receptors 2item
  91. 5-HT1 Receptors 1 item
  92. 5-HT7 Receptors 1 item
  93. Pancreatic and duodenal homeobox 1 (PDX1) 1 item
  94. 5-HT3 Receptors 1 item
  95. Autophagy 1 item
  96. Mixed lineage kinase domain-like protein (MLKL) 1 item
  97. COX 4item
  98. IDH2 1 item
  99. Squalene epoxidases 1 item
  100. P2X Receptors 1 item
  101. Ron 1 item
  102. Synthases/Synthetases 1 item
  103. TAK1 1 item
  104. Histamine H1 Receptors 1 item
  105. Phospholipases 1 item
  106. IL Receptors 1 item
  107. CCL2 1 item
  108. Calcium-Activated Potassium (KCa) Channels 1 item
  109. AChE 1 item
  110. Proton Pump 1 item
  111. cAMP 1 item
  112. Sulfonylurea receptors 1 item
  113. Peptidoglycan synthesis 1 item
  114. Nuclear Receptors 1 item
  115. Catechol O-Methyltransferase (COMT) 1 item
  116. Angiotensin AT1 Receptors 1 item
  117. Hydroxylases 1 item
  118. DREADD Ligands 1 item
  119. PP4 1 item
  120. AChR 1 item
  121. sodium channels 1 item
  122. Fyn kinase 1 item
  123. KDM 1 item
  124. Ub-conjugating enzyme (E2) complex 1 item
  125. Nrf2/ARE signal 1 item
  126. PPAR 3item
  127. IKK 1 item
  128. PC-PLC 1 item
  129. P97 ATPase 1 item
  130. Antibiotic 1 item
  131. Hec1 1 item
  132. Calmodulins 1 item
  133. ErbB-2 1 item
  134. adrenergic receptor 1 item
  135. TRPA 1 item
  136. Histone Acetyltransferases (HATs) 1 item
  137. constitutive androstane receptor (CAR) 1 item
  138. Tyrosinases 1 item
  139. ITK 1 item
  140. NUAK 1 item
  141. SERT 1 item
  142. prolactin secretion 1 item
  143. gonadotropin release 1 item
  144. 5-HT receptor 1 item
  145. 5-alpha Reductases 1 item
  146. NOP Receptors 1 item
  147. Transferases 1 item
  148. Dopamine receptor 1 item
  149. Histamine receptor 1 item
  150. DHFR 1 item
  151. GARFT 1 item
  152. Octamer-binding transcription factor 4 (Oct4) 1 item
  153. GLP-2 receptor 1 item
  154. PRMT 1 item
  155. epoxide hydrolase 1 item
  156. Serotonin (5-HT) reuptake 1 item
  157. Histone Methyltransferase 1 item
  158. NE 1 item
  159. PIKfyve 1 item
Reported Experiments
  1. Animal Experiments 178item
  2. Cell Experiments 136item
Related Disease
  1. Acute Myelogenous Leukemia 3item
  2. Acute Myeloid Leukemia 2item
  3. Adrenocortical Carcinoma 1 item
  4. Anesthesia 1 item
  5. Bladder Cancer 2item
  6. B-lymphoid Malignancies 1 item
  7. Brain Injuries Studies 1 item
  8. Breast Cancer 22item
  9. Cancer 89item
  10. Chronic Lymphocytic Leukemia 2item
  11. Cocaine-Related Disorders 1 item
  12. Colon Cancer 7item
  13. Colorectal Cancer 11item
  14. Depression 1 item
  15. Diabetes 3item
  16. Glioblastoma 7item
  17. Glioma 5item
  18. Hepatocellular Carcinoma 2item
  19. HIV 2item
  20. Inflammatory Diseases 1 item
  21. Leukemia 1 item
  22. Lung Cancer 4item
  23. Lung Carcinoma 2item
  24. Lymphoma 6item
  25. Mantle Cell Lymphoma 2item
  26. Melanoma 8item
  27. Multiple Myeloma 5item
  28. Myeloma 2item
  29. Neuroblastoma 4item
  30. Neurocognitive Disorders 1 item
  31. Non-small Cell Lung Cancer 5item
  32. Obsessive-Compulsive Disorder 1 item
  33. Osteoporosis 1 item
  34. Ovarian Cancer 6item
  35. Pancreatic Cancer 8item
  36. Prostate Cancer 7item
  37. Renal Cancer 1 item
  38. Renal Cell Carcinoma 2item
  39. Rheumatoid Arthritis 1 item
  40. Schizophrenia 2item
  41. Thyroid Cancer 1 item
  42. Type 2 Diabetes 2item